The following laboratory assessments were measured by standard methods using fasting venous blood samples, which were taken between 8 and 9 a.m
Cancer Research: The peptide shows significant potential as a tumor suppressor in cancer therapy by targeting and eliminating senescent cancer cells, which often arise from DNA damage and contribute to cancer progression and recurrence
Real-world outcomes depend on proper injection technique, refrigeration, and ongoing provider monitoring
The trial did report a skin-related effect, described as cutaneous hyperesthesia and skin sensitivity, in about 7% of people on retatrutide compared with 1% on placebo, but it did not report alopecia or hair loss as a distinct side effect
This study utilized publicly available, de-identified data from the FDA Adverse Event Reporting System (FAERS), and therefore did not involve direct interaction with human participants or identifiable private information